Caisse Des Depots ET Consignations Acquires Shares of 5,435 Pulse Biosciences, Inc. (NASDAQ:PLSE)

Caisse Des Depots ET Consignations bought a new position in Pulse Biosciences, Inc. (NASDAQ:PLSE) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 5,435 shares of the company’s stock, valued at approximately $95,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PLSE. KLP Kapitalforvaltning AS bought a new stake in Pulse Biosciences in the 4th quarter valued at $44,000. Farther Finance Advisors LLC grew its position in shares of Pulse Biosciences by 44.4% during the fourth quarter. Farther Finance Advisors LLC now owns 7,220 shares of the company’s stock valued at $126,000 after purchasing an additional 2,220 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of Pulse Biosciences in the fourth quarter worth about $193,000. Bender Robert & Associates purchased a new stake in shares of Pulse Biosciences in the fourth quarter worth about $202,000. Finally, Oppenheimer & Co. Inc. bought a new position in Pulse Biosciences during the fourth quarter valued at approximately $311,000. Institutional investors own 76.95% of the company’s stock.

Pulse Biosciences Stock Performance

Shares of PLSE stock opened at $16.60 on Friday. The stock’s 50 day simple moving average is $18.81 and its two-hundred day simple moving average is $18.16. Pulse Biosciences, Inc. has a 1 year low of $6.60 and a 1 year high of $25.00.

Analyst Ratings Changes

Separately, StockNews.com raised Pulse Biosciences to a “sell” rating in a report on Thursday, January 2nd.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.